Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-BroMo-5-(trifluoroMethyl)anisole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

627527-23-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 627527-23-5 Structure
  • Basic information

    1. Product Name: 3-BroMo-5-(trifluoroMethyl)anisole
    2. Synonyms: 3-BroMo-5-(trifluoroMethyl)anisole;1-Bromo-3-methoxy-5-trifluoromethylbenzene;3-Bromo-5-methoxybenzotrifluoride
    3. CAS NO:627527-23-5
    4. Molecular Formula: C8H6BrF3O
    5. Molecular Weight: 255.0318496
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 627527-23-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 201℃
    3. Flash Point: 93℃
    4. Appearance: /
    5. Density: 1.563
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-BroMo-5-(trifluoroMethyl)anisole(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-BroMo-5-(trifluoroMethyl)anisole(627527-23-5)
    11. EPA Substance Registry System: 3-BroMo-5-(trifluoroMethyl)anisole(627527-23-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 627527-23-5(Hazardous Substances Data)

627527-23-5 Usage

Chemical Properties

light yellow liquid

Check Digit Verification of cas no

The CAS Registry Mumber 627527-23-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,7,5,2 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 627527-23:
(8*6)+(7*2)+(6*7)+(5*5)+(4*2)+(3*7)+(2*2)+(1*3)=165
165 % 10 = 5
So 627527-23-5 is a valid CAS Registry Number.

627527-23-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (JWP00019)  1-Bromo-3-methoxy-5-trifluoromethyl-benzene  AldrichCPR

  • 627527-23-5

  • JWP00019-1G

  • 966.42CNY

  • Detail

627527-23-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Bromo-3-methoxy-5-(trifluoromethyl)benzene

1.2 Other means of identification

Product number -
Other names 3-Bromo-5-(trifluoromethyl)anisole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:627527-23-5 SDS

627527-23-5Relevant articles and documents

NOVEL TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

-

Page/Page column 167, (2016/07/27)

The invention provides novel compounds having the general formula (I): wherein R1, R2, R3, Q, U,W, Z, X and Y are as described herein, compositions including the compounds and methods of using the compounds. These compounds are HbsAg inhibitors and are useful as medicaments for the treatment or prophylaxis of HBV infection.

Substituted N-Phenyl-1-(4-Pyridinyl)-1H-Pyrazol-3-Amines

-

Page/Page column 17, (2012/07/14)

The present invention relates to N-phenyl-1-(4-pyridinyl)-1H-pyrazol-3-amine derivatives and pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, according to formula (I) Wherein R1, R2, R3, R4, R5, R6 have the meaning defined in the claims. The invention particularly relates to positive allosteric modulators of nicotinic acetylcholine receptors, such positive allosteric modulator having the capability to increase the efficacy of nicotinic receptor agonists.

SUBSTITUTED N-PHENYL-1-(4-PYRIDINYL)-1H-PYRAZOL-3-AMINES

-

Page/Page column 38, (2011/04/19)

The present invention relates to N-phenyl-1-(4-pyridinyl)-1H-pyrazol-3-amine derivatives and pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, according to formula (I): wherein R1, R2, R3, R4, R5, R6 have the meaning defined in the claims. The invention particularly relates to positive allosteric modulators of nicotinic acetylcholine receptors, such positive allosteric modulator having the capability to increase the efficacy of nicotinic receptor agonists.

Meta halogenation of 1,3-disubstituted arenes via iridium-catalyzed arene borylation

Murphy, Jaclyn M.,Liao, Xuebin,Hartwig, John F.

, p. 15434 - 15435 (2008/09/19)

We report the meta halogenation of 1,3-disubstituted arenes to form 3,5-disubstituted aryl bromides and chlorides by using iridium-catalyzed arene borylation chemistry. Iridium-catalyzed borylation of arenes with B2pin2, followed by reaction of the boronic ester with copper(II) bromide or chloride converts arylboronic esters to the corresponding aryl halides. A variety of arenes containing alkoxy, alkyl, halogen, nitrile, ester, amide, and pivaloyl and TIPS-protected alcohols were converted to the corresponding 3,5-disubstituted aryl bromides and chlorides in yields ranging from 46% to 85%. In addition, 2,6-disubstituted and 3-substituted pyridines were converted to the 4-halo and 5-halopyridines, respectively. The utility of this methodology was demonstrated by the formal conversion of nicotine to Altinicline in three steps with an overall yield of 61% using meta bromination of nicotine as the first step. Copyright

Substituted imidazol-pyridazine derivatives

-

Page 22, (2010/02/05)

The present invention relates to compounds of formula wherein A is an unsubstituted or substituted cyclic group; and R is hydrogen or lower alkyl; or a pharmaceutically acceptable acid addition salt thereof. These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 627527-23-5